Q1 2015 13F Holders as of 31 Mar 2015
-
Type / Class
-
Equity / ISHARES BIOTECH
-
Total 13F shares
-
18,652,504
-
Share change
-
+1,885,048
-
Total reported value
-
$6,405,375,888
-
Put/Call ratio
-
249%
-
Price per share
-
$343.43
-
Number of holders
-
391
-
Value change
-
+$719,078,060
-
Number of buys
-
201
-
Number of sells
-
147
Institutional Holders of ISHARES TR - ISHARES BIOTECH (IBB) as of Q1 2015
As of 31 Mar 2015,
ISHARES TR - ISHARES BIOTECH (IBB) was held by
391 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
18,652,504 shares.
The largest 10 holders included
GOLDMAN SACHS GROUP INC, MORGAN STANLEY, BNP PARIBAS ARBITRAGE, SA, JPMORGAN CHASE & CO, BANK OF AMERICA CORP /DE/, CITIGROUP INC, UBS Group AG, Beaumont Financial Partners, LLC, MANAGED ACCOUNT ADVISORS LLC, and CHURCHILL MANAGEMENT Corp.
This page lists
391
institutional shareholders reporting positions in this security
for the Q1 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.